ASHISH JAIN et al. 2015. CONSTITUTIVELY ACTIVATED TYROSINE KINASE INHIBITOR DRUG DESIGN: HOMOLOGY MODELING AND DOCKING STUDIES ON CHRONIC MYELOGENOUS LEUKEMIA BCR-ABL FUSION PROTEIN. International Journal of Pharma and Bio Sciences. 6, 2 (Jun. 2015), 1215–1225.